Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson's Disease:a Multi-center Placebo-controlled Trial.

NCT01856738 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT01856738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01856738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson's Disease:a Multi-center Placebo-controlled Trial.
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2013
Completion date
September 30, 2018
Enrollment
91 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease